1. Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors
   Hannah Schindler et al, 2022, Frontiers in Oncology CrossRef
2. Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice
   Jiajia Wu et al, 2023, Frontiers in Endocrinology CrossRef